Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein‐Barr virus‐encoded nuclear antigen EBNA I

No abstract is available for this paper.

• Publication year

  1993

• Venue

  European Journal of Immunology

• Publication date

  1993-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830230525PMID 8386666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epstein‐barr‐virus‐encoded membrane protein LMP but not the nuclear antigen EBNA‐1 induces rejection of transfected murine mammary carcinoma cells

  1991cited by this paper
• Very long charge runs in systemic lupus erythematosus-associated autoantigens.

  1991cited by this paper
• Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin.

  1991cited by this paper
• Plasmodium berghei Subunit Vaccine: Repeat Synthetic Peptide of Circumsporozoite Protein Comprising T‐ and B‐Cell Epitopes Fails to Confer Immunity

  1990cited by this paper
• Expression of the Epstein‐Barr virus (EBV)‐encoded membrane antigen (LMP) increases the stimulatory capacity of EBV‐negative B lymphoma lines in allogeneic mixed lymphocyte cultures

  1990cited by this paper
• An immunoglobulin light chain from a lupus-prone mouse induces autoantibodies in normal mice

  1990cited by this paper
• Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus

  1990cited by this paper
• Use of T7 RNA polymerase to direct expression of cloned genes.

  1990cited by this paper
• Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: implications for the pathogenesis of rheumatoid arthritis.

  1990cited by this paper
• Small nuclear RNA associated proteins: autoantigens in connective tissue diseases.

  1989cited by this paper
• Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

  1989cited by this paper
• Viral latency and transformation: the strategy of Epstein-Barr virus.

  1989cited by this paper
• Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

  1988cited by this paper
• Molecular cloning of a cDNA encoding the human Sm-D autoantigen.

  1988cited by this paper
• A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen.

  1987cited by this paper
• Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen

  1987cited by this paper
• Systemic autoimmune disease arises from polyclonal B cell activation

  1987cited by this paper
• Cellular and humoral immune responses to synthetic peptides deduced from the amino‐acid sequences of Epstein‐Barr virus‐encoded proteins in EBV‐transformed cells

  1987cited by this paper
• Paired Epstein‐Barr virus (EBV)‐negative and EBV‐converted Burkitt lymphoma lines: Stimulatory capacity in allogeneic mixed lymphocyte cultures

  1987cited by this paper
• Human autoimmune serum antibodies against gag gene p30 retroviral protein also react with a U1‐SnRNP 68K comigrant protein

  1987cited by this paper
• Molecular mimicry and autoimmune disease.

  1987cited by this paper
• Immunization of mice with purified U1 small nuclear ribonucleoprotein (RNP) induces a pattern of antibody specificities characteristic of the anti-Sm and anti-RNP autoimmune response of patients with lupus erythematosus, as measured by monoclonal antibodies.

  1986cited by this paper
• Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.

  1985cited by this paper
• Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen

  1984cited by this paper
• Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.

  1984cited by this paper
• A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

  1984cited by this paper
• Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes.

  1982cited by this paper
• The polyamide method of solid phase peptide and oligonucleotide synthesis

  1979cited by this paper
• Lymphocyte specificity to protein antigens. I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice.

  1977cited by this paper
• Antigenicity: some molecular aspects.

  1969cited by this paper

• Epstein–Barr virus infection and rheumatic diseases

  2026cites this paper
• Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases

  2025cites this paper
• Exploring the Association between Epstein-Barr Virus and Systemic Lupus Erythematosus: Insights into Viral Triggers

  2025cites this paper
• EBV and Autoimmunity.

  2025cites this paper
• Prognostic insights from symptom clustering analysis in systemic lupus erythematosus

  2025cites this paper
• Epstein–Barr virus as a potentiator of autoimmune diseases

  2024cites this paper
• Molecular mimicry as a mechanism of viral immune evasion and autoimmunity

  2024cites this paper
• Molecular Mimicry as a Mechanism of Viral Immune Evasion and Autoimmunity

  2024cites this paper
• Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases

  2024cites this paper
• MMPred: a tool to predict peptide mimicry events in MHC class II recognition

  2024cites this paper
• Antibody Cross-Reactivity in Auto-Immune Diseases

  2023cites this paper
• Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus

  2023cites this paper
• Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy

  2023cites this paper
• Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity

  2023cites this paper
• Immunological Aspects of Reactivation of Latent Infections in Space Flight and Antarctica

  2023cites this paper
• The distribution of heterophilic antigens and their relationship with autoimmune diseases

  2023cites this paper
• TLR7 activation of age-associated B cells mediates disease in a mouse model of primary Sjögren's disease.

  2023cites this paper
• Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus

  2022cites this paper
• A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies

  2022cites this paper
• Epstein-Barr virus and multiple sclerosis

  2022cites this paper
• Preclinical stage abundance and nuclear antigen reactivity of fecal Immunoglobulin A (IgA) varies among males and females of lupus-prone mouse models

  2022cites this paper
• Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus

  2021cites this paper
• Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.

  2021cites this paper
• Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus

  2021cites this paper
• Antibodies to an Epstein Barr Virus protein that cross-react with dsDNA have pathogenic potential.

  2021cites this paper
• Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus

  2021cites this paper
• Epstein–Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity

  2020cites this paper
• Abundance and nuclear antigen reactivity of intestinal and fecal Immunoglobulin A in lupus-prone mice at younger ages correlate with the onset of eventual systemic autoimmunity

  2020cites this paper
• Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site

  2019cites this paper
• Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice

  2019influential citation
• Silica exposure and chronic virus infection synergistically promote lupus-like systemic autoimmunity in mice with low genetic predisposition.

  2019cites this paper
• Molecular mimicry and autoimmunity.

  2018cites this paper
• Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System

  2018cites this paper
• Molecular mimicry: An explanation for autoimmune diseases and infertility

  2018influential citation
• The Possible Effect of B-Cell Epitopes of Epstein–Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus

  2018cites this paper
• B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice

  2017cites this paper
• Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA

  2016cites this paper
• Autoimmunity, neuroinflammation, pathogen load: A decisive crosstalk in neuropsychiatric SLE.

  2016cites this paper
• The role of monogamous bivalency and Fc interactions in the binding of anti-DNA antibodies to DNA antigen.

  2016cites this paper
• Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.

  2016cites this paper
• Epstein-Barr Virus (EBV) Encoded Dutpase Exacerbates the Immune pathology of Lupus Nephritis In Vivo

  2016cites this paper
• Aberrant expression of epstein-barr virus genes in Juvenile systemic lupus erythematosus

  2016cites this paper
• EBV and Autoimmunity.

  2015cites this paper
• Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses.

  2015cites this paper
• Molecular Mimicry and Autoimmunity

  2015cites this paper
• IL10 mRNA stability defects as a mechanism contributing to the development of lupus

  2015cites this paper
• Cardiovascular Disease and Immune Mechanisms in Systemic Lupus Erythematosus

  2014cites this paper
• Promoter Polymorphisms in Interferon Regulatory Factor 5

  2013cites this paper
• Ectopic lymphoid structures support Epstein-Barr virus persistence and autoreactive plasma cell infection in Rheumatoid Arthritis synovium and Sjogren’s Syndrome salivary glands

  2013cites this paper
• Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases

  2012influential citation
• Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions

  2012cites this paper
• Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation

  2012cites this paper
• Chronic Exposure to Staphylococcal Superantigen Elicits a Systemic Inflammatory Disease Mimicking Lupus

  2012cites this paper
• Epstein–Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis

  2012cites this paper
• Prevalence of human herpesvirus 8 infection in systemic lupus erythematosus

  2011cites this paper
• Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

  2011cites this paper
• Sm peptides in differentiation of autoimmune diseases.

  2011cites this paper
• Chapter 21 – SYSTEMIC LUPUS ERYTHEMATOSUS

  2011cites this paper
• [Detection of serum anti-B/B' UsnRNP antibodies in patients with connective tissue diseases by immunoblotting].

  2011cites this paper
• Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease.

  2011cites this paper
• Synthesis of a l-lysine-based alternate alpha,epsilon-peptide: a novel linear polycation with nucleic acids-binding ability.

  2010cites this paper
• Antibodies Elicited in Response to EBNA-1 May Cross-React with dsDNA

  2010cites this paper
• Infection in systemic lupus erythematosus: friend or foe?

  2010cites this paper
• Endogenous retroviral pathogenesis in lupus

  2010cites this paper
• Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study

  2010cites this paper
• Aberrant Epstein-Barr viral infection in systemic lupus erythematosus.

  2009cites this paper
• The use of post‐translationally modified peptides for detection of biomarkers of immune‐mediated diseases

  2009cites this paper
• Infectious antibodies in systemic lupus erythematosus patients

  2009cites this paper
• Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes.

  2009cites this paper
• Molecular mimicry in systemic lupus erythematosus

  2009cites this paper
• Regulation and dysregulation of Epstein–Barr virus latency: Implications for the development of autoimmune diseases

  2008cites this paper
• Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE

  2008cites this paper
• Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis.

  2008cites this paper
• Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan

  2007cites this paper
• Mechanisms of anti-Sm B cell activation in autoimmune Fas-deficient mice

  2007cites this paper
• Auto-antibody profiles in patients with active pulmonary tuberculosis.

  2007cites this paper
• Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus

  2006influential citation
• Systemic lupus erythematosus due to Epstein–Barr virus or Epstein–Barr virus infection provocating acute exacerbation of systemic lupus erythematosus?

  2006cites this paper
• Induction of Pathogenic Anti-dsDNA Antibodies Is Controlled on the Level of B Cells in a Non-Lupus Prone Mouse Strain

  2006cites this paper
• EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity1

  2006cites this paper
• An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus.

  2006cites this paper
• Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis.

  2006cites this paper
• Heart‐ and skeletal muscle‐specific antigens recognized by trichinellosis patient sera

  2006cites this paper
• NOVEL IMMUNOLOGICAL MECHANISMS AND FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS-RELATED CARDIOVASCULAR DISEASE

  2006cites this paper
• Advances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptides.

  2005cites this paper
• Systemic lupus erythematosus.

  2005cites this paper
• S‹STEM‹K LUPUS ER‹TEMATOZUS ETYOPATOGENEZ‹NDE V‹RÜSLER‹N ROLÜ

  2005cites this paper
• POSSIBLE MECHANISMS BY WHICH EBV INFECTION COULD PROMOTE AUTOIMMUNE DISEASE

  2005cites this paper
• Anti-Sm and anti-RNP antibodies

  2005cites this paper
• Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

  2005cites this paper
• A Deiminated Viral Peptide to Detect Antibodies in Rheumatoid Arthritis

  2005cites this paper
• Exogenous Factors in Cutaneous Lupus Erythematosus

  2004cites this paper
• Pathogenesis of SLE: implications for rational therapy

  2004cites this paper
• Epstein-Barr Virus and Autoimmunity

  2004cites this paper
• Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies.

  2004cites this paper
• Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: A review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual

  2004cites this paper
• The Epstein-Barr virus in autoimmunity

  2004cites this paper
• Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood

  2004cites this paper
• Peptide-based immunotherapy of systemic lupus erythematosus.

  2004cites this paper
• Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies

  2004cites this paper